List of Agenus patents

List of Agenus patents

List of Natus Medical patents

List of Tractor Supply Company patents

List of Otologics patents

List of AI construction companies

List of companies in The Syndicate Group's investment portfolio

Patents where

Current Assignee

Name

is

Agenus

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11692042 Anti-CD73 antibodies and methods of use thereof	Patent 11692042 was granted and assigned to Agenus on July, 2023 by the United States Patent and Trademark Office.	Agenus	Agenus		United States Patent and Trademark Office	11692042	July 4, 2023
	‌ US Patent 10882908 Anti-LAG-3 antibodies and methods of use thereof	Patent 10882908 was granted and assigned to Agenus on January, 2021 by the United States Patent and Trademark Office.	Agenus	Agenus		United States Patent and Trademark Office	10882908	January 5, 2021
	‌ US Patent 10912828 Anti-TIM-3 antibodies and methods of use thereof	Patent 10912828 was granted and assigned to Agenus on February, 2021 by the United States Patent and Trademark Office.	Agenus	Agenus		United States Patent and Trademark Office	10912828	February 9, 2021
	‌ US Patent 11021537 Anti-TIGIT antibodies and methods of use thereof	Patent 11021537 was granted and assigned to Agenus on June, 2021 by the United States Patent and Trademark Office.	Agenus	Agenus		United States Patent and Trademark Office	11021537	June 1, 2021
	‌ US Patent 10844119 Anti-LAG-3 antibodies and methods of use thereof	Patent 10844119 was granted and assigned to Agenus on November, 2020 by the United States Patent and Trademark Office.	Agenus	Agenus		United States Patent and Trademark Office	10844119	November 24, 2020
	‌ US Patent 10639368 Anti-TIM-3 antibodies and methods of use thereof	Patent 10639368 was granted and assigned to Agenus on May, 2020 by the United States Patent and Trademark Office.	Agenus	Agenus		United States Patent and Trademark Office	10639368	May 5, 2020
	‌ US Patent 11242385 Anti-CD137 antibodies and methods of use thereof	Patent 11242385 was granted and assigned to Agenus on February, 2022 by the United States Patent and Trademark Office.	Agenus	Agenus		United States Patent and Trademark Office	11242385	February 8, 2022
	‌ US Patent 9593327 Identification of antigen or ligand-specific binding proteins	Patent 9593327 was granted and assigned to Agenus on March, 2017 by the United States Patent and Trademark Office.	‌ 4-Antibody AG	Agenus		United States Patent and Trademark Office	9593327	March 14, 2017
	‌ US Patent 9645146 Cell surface display, screening and production of proteins of interest	Patent 9645146 was granted and assigned to Agenus on May, 2017 by the United States Patent and Trademark Office.	Agenus	Agenus		United States Patent and Trademark Office	9645146	May 9, 2017
	‌ US Patent 10568948 Vaccines for treatment and prevention of cancer	Patent 10568948 was granted and assigned to Agenus on February, 2020 by the United States Patent and Trademark Office.	Agenus	Agenus		United States Patent and Trademark Office	10568948	February 25, 2020
	‌ US Patent 11065317 Heat shock protein-binding peptide compositions and methods of use thereof	Patent 11065317 was granted and assigned to Agenus on July, 2021 by the United States Patent and Trademark Office.	Agenus	Agenus		United States Patent and Trademark Office	11065317	July 20, 2021
	‌ US Patent 10502745 Identification of antigen- or ligand-specific binding proteins	Patent 10502745 was granted and assigned to Agenus on December, 2019 by the United States Patent and Trademark Office.	Agenus	Agenus		United States Patent and Trademark Office	10502745	December 10, 2019
	‌ US Patent 8541002 Vaccine for treatment and prevention of herpes simplex virus infection			Agenus		United States Patent and Trademark Office	8541002	September 24, 2013
	‌ US Patent 11680098 Antibodies that specifically bind human CD96		Agenus	Agenus		United States Patent and Trademark Office	11680098	June 20, 2023
	‌ US Patent 11839653 Anti-TIM-3 antibodies and methods of use thereof	Patent 11839653 was granted and assigned to Agenus on December, 2023 by the United States Patent and Trademark Office.	Agenus	Agenus		United States Patent and Trademark Office	11839653	December 12, 2023
	‌ US Patent 11993651 Anti-lag-3 antibodies and methods of use thereof	Patent 11993651 was granted and assigned to Agenus on May, 2024 by the United States Patent and Trademark Office.	Agenus	Agenus		United States Patent and Trademark Office	11993651	May 28, 2024
	‌ US Patent 12011481 Anti-TIM-3 antibodies and methods of use thereof	Patent 12011481 was granted and assigned to Agenus on June, 2024 by the United States Patent and Trademark Office.	Agenus	Agenus		United States Patent and Trademark Office	12011481	June 18, 2024

17 results

0 selected

17 results

0 selected